Zydus Cadila begins supply of its anti-Covid vaccine to Centre | Latest News India - Hindustan Times
close_game
close_game

Zydus Cadila begins supply of its anti-Covid vaccine to Centre

By, New Delhi
Feb 02, 2022 10:21 AM IST

ZyCoV-D, which was cleared by the DCGI in August last year, is a needle-less vaccine, and will be administered in three doses.

ZyCoV-D, the anti-Covid vaccine developed by Ahmedabad-based Zydus Cadila, is all set to be included in the ongoing nationwide inoculation drive, as according to the company, it has started supplying the first batch of the vaccine to the Union government.

A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)
A doctor being inoculated with a booster dose of Covid-19 vaccine, at Ganga Ram Hospital, in New Delhi. (Amal KS/HT Photo)

“We have started the supply of the three-dose ZyCoV-D to the Government of India. We are also planning to make it available in the private market,” news agency ANI quoted the pharmaceutical firm as saying in a statement.

Hindustan Times - your fastest source for breaking news! Read now.

 

ZyCoV-D, which received emergency use authorisation (EUA) from the Drugs Controller General of India (DCGI) in August last year, is the only needle-free coronavirus vaccine in the world. It is also the world's first Plasmid DNA vaccine, and will be administered on days 0, 28 and 56.

It has been priced at 358 per dose ( 265 for individual dose plus 93 for the applicator through which it will be administered each time), which means that in all, a beneficiary will have to spend 1074 to be inoculated with ZyCoV-D. However, the final price is a significant reduction from the 1900 initially quoted by the developers.

The vaccine, which was cleared for the age group of 12 and above, was the first to be granted EUA for an age group below 18. Also, while the inoculation drive began on January 16 last year, teenagers aged 15-18 became eligible for vaccination only on January 3 this year.

For now, Hyderabad-based Bharat Biotech's twin-dose Covaxin is the only jab which is being used to vaccinate teenagers. Covaxin and ZyCoV-D, in that order, are also India's first two indigenous vaccines against this viral illness.

 

 

 

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On